Birth Cohort Study of China Medical University

Launched by SHENGJING HOSPITAL · Jun 17, 2018

Keywords

ClinConnect Summary

The Birth Cohort Study of China Medical University (CMUBCS) is a research project based in Shenyang, China, focusing on understanding how both genes and environmental factors can influence health and disease in pregnant women and their children. This study is particularly interested in women who are pregnant with twins, are of advanced maternal age, have a scarred uterus, or are overweight or obese. The researchers will collect information about the mothers' lifestyles, medical history, and various health outcomes during pregnancy, as well as biological samples like blood and tissue from both the mothers and their children, who will be followed from birth up to 18 years old.

To participate in this study, women must be pregnant and less than 13 weeks along, live in Shenyang or nearby areas, and plan to give birth at Shengjing Hospital. Women who choose not to participate or have certain medical conditions that could affect the study results, such as mental health disorders, will not be eligible. By taking part in this research, participants can help contribute to important discoveries that may improve health outcomes for future generations.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • 1. Pregnant women, \<13 gestational weeks
• • 2. Permanent residents or families intended to remain in Shenyang and surrounding areas
• • 3. Pregnant women who are planned to be examined and delivered in Shengjing Hospital.
• Exclusion Criteria:
• • 1. Pregnant women who refuse to take part in the study
• • 2. Pregnant women have diseases that might affect the results of researches, including neuropsychiatric disorders.